• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

Eli Lilly will consider lower insulin prices, CEO says

cafead

Administrator
Staff member
  • cafead   Jun 30, 2021 at 12:32: AM
via Eli Lilly CEO David Ricks told CNBC June 29 that the drugmaker will look for new ways to cut insulin prices in the face of competition from Walmart, which launched its own private label insulin at nearly half the price of Eli Lilly's.

article source
 

<